Concepedia

H Fukutani

HF

13

Publications

737

Citations

13

H-Index

1992

Active since

Affiliations

Nagoya University Hospital(Current)

Mitsubishi Group (Japan)

Aichi Cancer Center

Nagoya University

H Fukutani is an author at Nagoya University Hospital specializing in medicine, autoimmunity, and cancer research.

Top concepts

Publications per year

1992–2018

13

Publications

13

Clinicopathologic and Prognostic Significance of Cytotoxic Molecule Expression in Nodal Peripheral T-Cell Lymphoma, Unspecified

Naoko Asano, Ritsuro Suzuki, Yoshitoyo Kagami et al. · The American Journal of Surgical Pathology · 2005 · 127 citations

, , +18

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

Masaya Okada, Jun Imagawa, Hideo Tanaka et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 116 citations · Full text

Prognostic Significance of T-Cell or Cytotoxic Molecules Phenotype in Classical Hodgkin’s Lymphoma: A Clinicopathologic Study

Naoko Asano, Aya Oshiro, Keitaro Matsuo et al. · Journal of Clinical Oncology · 2006 · 86 citations · Full text

Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare.

R Ohno, Hitoshi Yoshida, H Fukutani et al. · PubMed · 1993 · 82 citations

Bernard-Soulier syndrome Kagoshima: Ser 444-->stop mutation of glycoprotein (GP) Ib alpha resulting in circulating truncated GPIb alpha and surface expression of GPIb beta and GPIX [see comments]

Shinji Kunishima, Hitoshi Miura, H Fukutani et al. · Blood · 1994 · 60 citations · Full text

Rows per page

1–5 of 13